Mast cell stabilizer ketotifen reduces hyperalgesia in a rodent model of surgically induced endometriosis
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index; none of the 39 sources its claims cite is checked for support yet.
Abstract
Purpose: This study aimed to investigate the effect of oral treatment with ketotifen, a mast cell (MC) stabilizer, in a rat model of surgically induced endometriosis. Methods: At 14 days after Sprague–Dawley rats had surgery, they were treated with ketotifen (1 or 10 mg/kg/day). Pain behaviors were evaluated 3 days prior to surgery and then at 7, 14, 21, and 28 days after surgery. At day 28, rats were sacrificed and all samples were then processed for biochemical studies. Results: We found that ketotifen-treated rats showed significantly shorter duration of hyperalgesia ( p <0.05); smaller cyst diameter ( p <0.05) and lower histopathologic score ( p <0.001); significantly lower MC number and degranulation ( p <0.001), blood vessel number ( p <0.001), lower expression levels of nerve growth factor ( p <0.001), cyclooxygenase-2 ( p <0.001), intercellular cell adhesion molecule-1 ( p <0.001), and vascular endothelial growth factor ( p <0.05) in cysts, and nerve growth factor ( p <0.001) and transient receptor potential cation channel, subfamily V, member 1 ( p <0.001) in dorsal root ganglia; and lower histamine ( p <0.05) and tumor necrosis factor-alpha ( p <0.05) concentrations in serum compared with placebo-treated animal subjects. Conclusion: Oral treatment with ketotifen significantly suppressed the development of hyperalgesia, probably by modulating MC activity in cysts, thereby reducing peripheral sensitization due to noxious signals from endometriotic lesions. Our results suggest that ketotifen may inhibit the development of endometriotic lesions and hyperalgesia in rats. Keywords: endometriosis, ketotifen, rat, mast cells, hyperalgesia
Overview
CoChat Summary
TL;DR
In a surgically induced rat model of endometriosis, oral ketotifen reduced hyperalgesia and was associated with lower mast cell activity, smaller cysts, and reduced expression of several inflammatory/algogenic markers. The paper concludes ketotifen may be a mechanism-based candidate for endometriosis-associated pain, but notes that further experimental and clinical studies are needed.
Key findings
- Rats with experimental endometriosis had significantly lower mechanical thresholds and paw withdrawal latencies by day 14 after surgery than sham-operated rats; after 14 days of treatment, ketotifen (1 or 10 mg/kg/day) produced significantly higher thresholds than vehicle.
- Ketotifen reduced mast cell number and degranulation in endometriotic cysts: the control group had higher mast cell counts and degranulation rates than both ketotifen groups, with p < 0.001; there was no significant difference between 1 and 10 mg/kg.
- Ketotifen suppressed lesion pathology: cyst epithelium showed atrophy/regression, vessel number was lower than in controls (p < 0.001), and cyst size was smaller in both ketotifen groups (p < 0.05); no significant low-vs-high dose difference was seen for vessel number or cyst size.
- Ketotifen downregulated marker expression in cysts and DRG, including NGF, COX-2, ICAM-1, VEGF, NGF, and TRPV1; serum histamine and TNF-α were also reduced versus vehicle (p < 0.05), with some dose differences for NGF/ICAM-1 and TRPV1 but not for COX-2, VEGF, histamine, or TNF-α.
Methods
- Experimental design: female Sprague–Dawley rats with surgically induced endometriosis via autologous uterine horn transplantation were randomized to sham operation (n = 6), vehicle control (n = 6), ketotifen 1 mg/kg/day (n = 6), or ketotifen 10 mg/kg/day (n = 6); treatment was given by oral gavage from day 14 to day 28 after surgery.
- Outcomes measured: mechanical hyperalgesia (von Frey thresholds), thermal hyperalgesia (paw withdrawal latency), histology (endometriosis score, vessel number, cyst size), mast cell density/degranulation, IHC for NGF, COX-2, ICAM-1, VEGF, and DRG NGF/TRPV1, plus serum histamine and TNF-α by ELISA.
- Main analysis: data were summarized as mean ± SEM and compared by one-way ANOVA; Pearson correlation was used to relate mast cell number to pain behavior.
Limitations
- The paper explicitly states that “no clear dose–effect relationship was observed” and that further experimental and clinical studies will be needed for confirmation.
- Evident from the text: this is a small animal study with 6 rats per group, so generalizability to humans is limited.
- Evident from the text: treatment began 14 days after surgery, so the study addresses therapeutic effects after lesion establishment rather than prevention.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
0 Valid · 0 Not valid · 20 Not checked · 55 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“No significant difference was found in the low-dose and high-dose groups ( p >0.05).”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The number of vessels in the ketotifen-treated groups ( Figure 3D and E ) was lower than that in the control group ( Figure 3F ) ( p <0.001, Figure 3H ).”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Compared with rats in the sham group ( Figure 5A and E ), increased immunostaining of NFG and TRPV1 was observed in the DRG cells of rats with endometriosis ( p <0.001).”
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Similar expression patterns of NGF ( Figure 4A – C ), Cox-2 ( Figure 4D – F ), ICAM-1 ( Figure 4G – I ), and VEGF ( Figure 4J – L ) proteins were observed in the cytoplasm of endometriotic glandular cells and stromal cells.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“At day 28 of ketotifen or solvent (CMC-Na) intervention, rats administered with ketotifen (1 or 10 mg/kg/day) presented significantly higher MTs and PWL compared with those that received CMC-Na.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
37 more claims
Create a free account to see all 75 claims and to verify the 39 references still open.
- Probably not a substantial claim. 23
- It may state two separate claims as one. 12
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Zhu et al. [ 25 ] demonstrated in a rat model of surgically induced endometriosis that oral administration of ketotifen (a mast-cell stabilizer and HRH1 antagonist) significantly suppressed the development of hyperalgesia, likely by reducing mast-cell activity within lesions and thereby dampening peripheral sensitization.”
From The Histamine-Associated Inflammatory Landscape of Endometriosis: Molecular Profiling of HDC, HRH1-HRH4, and Cytokines Across Lesion Subtypes (2025) · cites this paper as [25]
In the citing paper
“Additional studies across diverse pain models have shown that mast-cell stabilizers and histamine-receptor antagonists reduce hyperalgesia [ 25 , 26 ], pelvic pain [ 27 ], inflammatory pain [ 28 ], and postoperative nociception [ 29 ], further supporting a central role for histamine-driven pathways in endometriosis-associated pain.”
From The Histamine-Associated Inflammatory Landscape of Endometriosis: Molecular Profiling of HDC, HRH1-HRH4, and Cytokines Across Lesion Subtypes (2025) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“The correlation between the number of MCs and pain behavior was determined through Pearson correlation.”
“Spearman analysis results showed that the number of total MCs was positively correlated with mechanical hyperalgesia”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“Our results showed that oral treatment also reduced TRPV1 repression in DRG cells”
“Treatment with ketotifen resulted in a reduction in immunoreactivity of NGF and TRPV1 in the DRG of rats with endometriosis”
Citations
Cites
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia
Hargreaves, K., Dubner, R., Brown, F., Flores, C., & Joris, J. (1988) · Pain · doi:10.1016/0304-3959(88)90026-7 · Cited by 5,135 · cited 1×
“Thermal hyperalgesia Paw withdrawal latency (PWL) to noxious heat stimuli was measured using an apparatus for measuring PWL (Model 336, IITC/Life Science, CA).(32) In brief, the rat was placed in a Plexiglas chamber with a bottom glass plate positioned above a light box.”
ESHRE guideline for the diagnosis and treatment of endometriosis
Kennedy, S., Bergqvist, A., Chapron, C., D’Hooghe, T., Dunselman, G., Greb, R., Hummelshoj, L., Prentice, A., & Saridogan, E. (2005) · Human Reproduction · doi:10.1093/humrep/dei135 · Cited by 1,584 · cited 1×
“In women with endometriosis-associated pain, several treatments are available including nonsteroidal anti-inflammatory drugs (NSAIDs), oral contraceptives, gonadotropin-releasing hormone (GnRH) agonists, and surgical treatment.(2) NSAIDs have significant side effects, including gastric ulceration(3) and anti-ovulatory…”
BackgroundJi, R.-R., Samad, T. A., Jin, S.-X., Schmoll, R., & Woolf, C. J. (2002) · Neuron · doi:10.1016/s0896-6273(02)00908-x · Cited by 1,238 · cited 1×
“Retrograde transport of NGF released from inflamed tissue acts to increase translation and transport of TRPV1 to the peripheral nociceptor terminal, where it contributes to the maintenance of inflammatory pain hypersensitivity.(40) Our results showed that oral treatment also reduced TRPV1 repression in DRG cells, whic…”
BackgroundMast cells synthesize, store, and release nerve growth factor.
Leon, A., Buriani, A., Dal Toso, R., Fabris, M., Romanello, S., Aloe, L., & Levi-Montalcini, R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3739 · Cited by 669 · cited 3×
“Our results showed that oral treatment also reduced TRPV1 repression in DRG cells, which may result from ketotifen blocking NGF release by MCs, since previous studies have reported that MCs can synthesize, store, and release NGF.(41) Our results also showed that endometriosis-afflicted rats treated with ketotifen had…”
ResultTumour necrosis factor-α induces ectopic activity in nociceptive primary afferent fibres
Sorkin, L. S., Xiao, W.-H., Wagner, R., & Myers, R. R. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00147-4 · Cited by 503
Prevention of NSAID-induced gastroduodenal ulcers
Rostom, A., Dube, C., Wells, G. A., Tugwell, P., Welch, V., Jolicoeur, E., McGowan, J., Lanas, A., Rushton, E., & Shukla, T. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002296 · Cited by 470
Strathy, J. H., Molgaard, C. A., Coulam, C. B., & Melton, L. J. (1982) · Fertility and Sterility · doi:10.1016/s0015-0282(16)46691-4 · Cited by 425 · cited 1×
“Introduction Endometriosis is characterized by the presence of endometrial glands and stroma outside the uterine cavity.(1) In women with endometriosis-associated pain, several treatments are available including nonsteroidal anti-inflammatory drugs (NSAIDs), oral contraceptives, gonadotropin-releasing hormone (GnRH) a…”
BackgroundBiedermann, T., Kneilling, M., Mailhammer, R., Maier, K., Sander, C. A., Kollias, G., Kunkel, S. L., Hültner, L., & Röcken, M. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.10.1441 · Cited by 395
Neurotrophins and hyperalgesia
Shu, X.-Q., & Mendell, L. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.7693 · Cited by 266 · cited 1×
“This result strongly supported the notion that ketotifen exerted its anti-algogenic effect by modulating NGF, one of the main mediators activating the algogenic input from the endometriosis lesions toward the nervous system.(39) Retrograde transport of NGF released from inflamed tissue acts to increase translation and…”
ResultPain, mast cells, and nerves in peritoneal, ovarian, and deep infiltrating endometriosis
Anaf, V., Chapron, C., El Nakadi, I., De Moor, V., Simonart, T., & Noël, J.-C. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.03.057 · Cited by 258 · cited 1×
“Human endometriotic lesions show significantly higher numbers of activated MCs, located less than 25 μm from nerve structures, than unaffected tissues.(6) Although the role of MCs in the mediation of nociceptive signaling needs to be explored further, MC-released products in endometriosis can contribute to the develop…”
Background
Cited by
Endometriosis: Etiology, pathobiology, and therapeutic prospects
Saunders, P. T. K., & Horne, A. W. (2021) · Cell · doi:10.1016/j.cell.2021.04.041 · Cited by 961
Guo, X., Xu, X., Li, T., Yu, Q., Wang, J., Chen, Y., Ding, S., Zhu, L., Zou, G., & Zhang, X. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.749979 · Cited by 88
“Further studies report that MCs activation by estrogen plays a crucial role in the development of endometriosis (19), yet its underlying molecular mechanisms require further investigation.”
BackgroundSelf-citationEndometriosis as an immune-mediated disease: pathogenetic mechanisms and therapeutic strategies
Shifon, S., Викторовна, Т. Т., Veretel’nikova, T. V., Пасман, Н. М., & Chernykh, E. R. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1727183 · Cited by 65
Hidrox® and Endometriosis: Biochemical Evaluation of Oxidative Stress and Pain
Cordaro, M., Salinaro, A. T., Siracusa, R., D’Amico, R., Impellizzeri, D., Scuto, M. C., Ontario, M. L., Interdonato, L., Crea, R., Fusco, R., et al. (2021) · Antioxidants · doi:10.3390/antiox10050720 · Cited by 51
“The reduced number and degranulation of mast cells in endometriotic lesions from the Hidrox®-treated group relate to suppressed neuropathic pain and release of inflammatory mediators [70].”
BackgroundArangia, A., Marino, Y., Fusco, R., Siracusa, R., Cordaro, M., D’Amico, R., Macrì, F., Raffone, E., Impellizzeri, D., Cuzzocrea, S., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065076 · Cited by 38
“Supplementary studies report that MCs play crucial roles in the development of endometriosis [7].”
BackgroundMacrophage-derived netrin-1 is critical for neuroangiogenesis in endometriosis
Guo, X., Ding, S., Li, T., Wang, J., Yu, Q., Zhu, L., Xu, X., Zou, G., Peng, Y., & Zhang, X. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.01.130 · Cited by 38
Self-citationIrandoost, E., Najibi, S., Talebbeigi, S., & Nassiri, S. (2022) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-022-02365-6 · Cited by 34
“Induction of mast cells by estrogen has been reported to play a vital role in the progress of EMS (Zhu et al. 2019).”
BackgroundXu, X., Wang, J., Guo, X., Chen, Y., Ding, S., Zou, G., Zhu, L., Li, T., & Zhang, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1106771 · Cited by 33
“), those with dual effects of mast cell stabilizers and histamine H1 receptor antagonists antiallergic drugs (such as ketotifen, olopatadine and azelastine) (57), and those targeting mast-cell degranulation, such as ketotifen (58), Janus kinase 3 inhibitors (59), phosphoinositide 3 kinase, and pathway neurokinin”
BackgroundSelf-citationNeuroproliferative dyspareunia in endometriosis and vestibulodynia
Mwaura, A. N., Marshall, N., Anglesio, M. S., & Yong, P. J. (2023) · Sexual Medicine Reviews · doi:10.1093/sxmrev/qead033 · Cited by 30
Szukiewicz, D., Wojdasiewicz, P., Wątroba, M., & Szewczyk, G. (2022) · Journal of Immunology Research · doi:10.1155/2022/9534163 · Cited by 26
Characterization of Early Inflammatory Events Leading to Provoked Vulvodynia Development in Rats
Awad-Igbaria, Y., Dadon, S., Shamir, A., Livoff, A., Shlapobersky, M., Bornstein, J., & Palzur, E. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s367193 · Cited by 20
“These results are consistent with earlier studies.(46) It was suggested that increased local nerve density and overexpression of pain channelsmight beMC-dependent and that the depletion ofMCs reduces innervation and downregulates pain-channels expressions.”
ResultGreaves, E., Rosser, M., & Saunders, P. T. K. (2020) · Advances in anatomy, embryology and cell biology · doi:10.1007/978-3-030-51856-1_3 · Cited by 15
The Role of Mast Cells in the Development and Advancement of Endometriosis
Makoui, M. H., Fekri, S. M., Makoui, R. H., Ansari, N. E., & Esmaeilzadeh, A. (2025) · American Journal of Reproductive Immunology · doi:10.1111/aji.70019 · Cited by 18
Yu, Q., Wang, J., Li, T., Guo, X., Ding, S., Che, X., Zhu, L., Peng, Y., Xu, X., Zou, G., et al. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16261 · Cited by 13
Self-citationEl-Dardiry, M. A., El-Aal, A. A. A., Abdeltawab, M. S. A., El‐Sherbini, M. S., Hassan, M. A., Abdel-Aal, A. A., Badawi, M., Anis, S. E., Khaled, B. E. A., & Al-Antably, A. S. (2021) · Parasites & Vectors · doi:10.1186/s13071-021-05075-9 · Cited by 14
“[32], pure powder of ketotifen was dissolved in carboxymethylcellulose sodium 0.”
MethodMao, X., Wang, J., Ding, S., Guo, X., Xu, X., Xu, P., & Zhang, X. (2025) · The FASEB Journal · doi:10.1096/fj.202501493r · Cited by 14
“Our previous studies revealed that mast cells mediate endometriosis-related pain in vitro and in a traditional mouse endometriosis model [7, 31].”
Self-citationBarrella, L., Ramírez-Ponce, M. P., Vázquez‐Román, V., Millán-Huang, M. S., y Aibar, M. D. M., Flores-Cordero, J. A., & Alés, E. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.106170 · Cited by 9
Investigation of the Therapeutic Effect of Salbutamol on Endometriosis in a Mouse Model
Yu, Q., Chen, L., Wang, J., Xu, X., Li, T., Guo, X., Yin, M., Mao, X., Zhu, L., Zou, G., et al. (2023) · Reproductive Sciences · doi:10.1007/s43032-023-01371-0 · Cited by 9
“The method of mast cell density measurement in tissue was previously described by Zhu et al. [22].”
Self-citationVelho, R. V., Freitag, J. H., Brueckner, A. M., Thalmeier, L., Pohl, J., & Mechsner, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms27010212 · Cited by 7
“Additional studies across diverse pain models have shown that mast-cell stabilizers and histamine-receptor antagonists reduce hyperal-gesia [25,26], pelvic pain [27], inflammatory pain [28], and postoperative nociception [29], further supporting a central role for histamine-driven pathways in…”
The therapeutic effects of coenzyme Q10 on surgically induced endometriosis in Sprague Dawley rats
Dizakar, S. Ö. A., Demirel, M. A., Akcay, N. C., Sipahi, M., Sokmensuer, L. K., Boyunağa, H., Köylü, A., & Ömeroğlu, S. (2022) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2022.2114322 · Cited by 8
“The count of Mast cells was evaluated in five fields (200�) per section (Zhu et al. 2019).”
MethodSrebro, D., Dožić, B., Vučković, S., Vujović, K. S., Medić, B., Dožić, I., & Srebro, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076241 · Cited by 9
“To elucidate how mast cells degranulate, future research should examine both the protective and destructive effects of a particular disease or the severity of the disease [32,36,37].”
BackgroundOmenge, H., Kempa, P. A., Jeong, J.-W., So, K. A., & Kim, T. H. (2026) · Endocrine Reviews · doi:10.1210/endrev/bnag019 · Cited by 8
The Unmet Needs for Studying Chronic Pelvic/Visceral Pain Using Animal Models
Neto, A. C., Santos-Pereira, M., Abreu‐Mendes, P., Neves, D., Almeida, H., Cruz, F., & Charrua, A. (2023) · Biomedicines · doi:10.3390/biomedicines11030696 · Cited by 6
Wang, T., Zheng, R., Qu, Y., Shu, P., Ai, W., Zhao, J., & Liu, L. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s537110 · Cited by 5
“104 The relationship between sex hormone dysregulation and inflammatory vesicle activation needs further exploration.”
CCL2/CCR4 participates in mast cell-mediated epithelial mesenchymal transition in endometriosis
Ding, S., Mao, X., Zhu, L., Xu, X., Chen, S., Zou, G., Xu, P., Wang, J., & Zhang, X. (2025) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2025.104796 · Cited by 6
Self-citationAn opinion on H1-antihistamines as a potential avenue for endometriosis management
Mantha, K. B. (2023) · AJOG Global Reports · doi:10.1016/j.xagr.2023.100274 · Cited by 6
Uncovering potential biomarkers of endometriosis: transcriptomic and single-cell analysis
Liu, Y., Gao, G., Tian, W. X., Lv, Q., Liu, D., & Li, C. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1528434 · Cited by 5
Howe, C. A., Coté, J. J., Stoos, C., Bredehoeft, M., Hallgren, J., & Waes, J. B. G. (2025) · Journal of the American Association for Laboratory Animal Science · doi:10.30802/aalas-jaalas-24-160 · Cited by 2
Aldossary, K. M., Talkhan, H., Abdulelah, F. M., Kotkata, F. A., Elmorsi, Y. M., Habba, E., Eltantawy, N., Mourad, S. A., Hamza, E., Sami, H. M., et al. (2026) · Drug Design Development and Therapy · doi:10.2147/dddt.s593561 · Cited by 2
Prisinzano, M., Seidita, I., Bruni, P., Petraglia, F., Bernacchioni, C., zu Heringdorf, D. M., & Donati, C. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.111876 · Cited by 3
Gynaecological Considerations in PoTS
Tailor, V. K., & Khullar, V. (2020) · Springer eBooks · doi:10.1007/978-3-030-54165-1_18 · Cited by 2
Lima, R. D. A., de Souza, I. B. J., Frota, G. M., Prazeres, T. C. M. M., Albuquerque, I. D. C., de Sousa, E. M., Cartágenes, M. D. S. S., Carvalho, R. C., Ferreira, A. D. S. P., & Garcia, J. B. S. (2023) · Veterinary World · doi:10.14202/vetworld.2023.2329-2339 · Cited by 1
Mast cell pathology and reproductive failures
Jesus, M. S. L. A., Alentajan-Aleta, L. T., Ocampo-Cervantes, C. C., Otadoy-Agustin, J. R., & Kwak-Kim, J. Y.-H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90805-4.00015-8 · Cited by 1
Adamietz, A., Müller, A., & Boosz, A. S. (2024) · Die Gynäkologie · doi:10.1007/s00129-024-05199-w · Cited by 1
Adamietz, A., Müller, A., & Boosz, A. S. (2024) · Deutsche Zeitschrift für Akupunktur · doi:10.1007/s42212-024-00656-y · Cited by 1
Wang, Y., Zhai, Q., Tian, Z., Chang, X., & Zhu, H. (2024) · Gynecology and Obstetrics Clinical Medicine · doi:10.1136/gocm-2024-000019
Tassinari, R., D’Archivio, M., Varí, R., Scazzocchio, B., Lori, G., Bellenghi, M., Silenzi, A., Tammaro, A., Marcoccia, D., Tassinari, V., et al. (2025) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-025-04913-y
“The same extract suppresses neuropathic pain and the release of inflammatory mediators [23] such as interleukin (IL)- 2, IL-1β, tumor necrosis factor (TNF)-α, IL-6 and IL-10 in the peritoneal fluid and endometriotic loci, as well as it restores the oxidant–antioxidant balance by increasing the…”
Advances in Ketotifen (API) Synthetic Methods, Starting Materials and Related Compounds: a Review
Ali, K. A. K., & Ragab, E. A. (2025) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-025-03372-6
Mantha, K. B., & Gajendran, M. K. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1538368 · Cited by 1
“…mast-cell behavior within ES patients, various studies have suggested mast-cell stabilizers (e.g., ketotifen) as a potential therapeutic avenue (91–93 H1-As are a class of drugs that function by stabilizing the HRH1 receptor through inverse agonist behavior (84), which are widely available and…”
Amato, A. C. M., Amato, J. L. S., & Benitti, D. A. (2025) · Cureus · doi:10.7759/cureus.99189
Amato, A. C. M., Amato, J. L. S., & Benitti, D. A. (2025) · medRxiv · doi:10.64898/2025.12.05.25341470
S1P2 Reduces Mast Cell Activation and Colonic Inflammation of L-Arginine-Induced Acute Pancreatitis
Zhang, R., Zhu, J., Qu, S., Chen, X., Wang, Y., Sun, L., Zhang, X., Lu, Z., & Wang, X. (2026) · Digestive Diseases and Sciences · doi:10.1007/s10620-026-09769-x
“Ketotifen (10 mg/kg) [18, 19], JTE-013 (4 mg/kg) [20], or CYM5520 (10 mg/kg) [21] was administered by oral gavage for two days before L-arginine injection, and three days after L-arginine injection.”
Self-citation
Metadata
- Authors
- Zhu, T.-H., Zou, G., Ding, S.-J., Li, T.-T., Zhu, L.-B., Wang, J.-Z., Yao, Y.-X., & Zhang, X.-M.
- Affiliations
- Women's Hospital, School of Medicine, Zhejiang University (CN)
- First Affiliated Hospital Zhejiang University (CN)
- Venue
- Journal of Pain Research
- Publisher
- Informa UK Limited
- Published
- 2019-04
- Volume
- Volume 12
- Pages
- 1359-1369
- ISSN
- 1178-7090 (ISSN-L)
- PMC
- PMC6500880
- OpenAlex
- W2941459715
- Cited by
- 43
- References
- 41
- Citations by year
- 2026: 3 · 2025: 14 · 2024: 3 · 2023: 10 · 2022: 5 · 2021: 5 · 2020: 3
- FWCI
- 3.11
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Pain Research (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Funders
- National Natural Science Foundation of China (81671429, 2017YFC1001202, 81471433, 81471127)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Life Sciences › Agricultural and Biological Sciences › Ecology, Evolution, Behavior and Systematics › Plant and fungal interactions
- Keywords
- ketotifen, mast cell stabilizers, endometriosis, hyperalgesia, surgically induced endometriosis, mast cell degranulation, peripheral sensitization, endometriotic cysts, nerve growth factor, cyclooxygenase-2, vascular endothelial growth factor, TRPV1, dorsal root ganglia, histamine, TNF-α
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.